SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-22-028904
Filing Date
2022-08-09
Accepted
2022-08-09 16:28:23
Documents
64
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10040598_10q.htm   iXBRL 10-Q 1349041
2 EXHIBIT 31.1 brhc10040598_ex31-1.htm EX-31.1 11195
3 EXHIBIT 31.2 brhc10040598_ex31-2.htm EX-31.2 11242
4 EXHIBIT 32.1 brhc10040598_ex32-1.htm EX-32.1 5878
10 image00001.jpg GRAPHIC 37567
  Complete submission text file 0001140361-22-028904.txt   6804694

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20220630.xsd EX-101.SCH 46656
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20220630_cal.xml EX-101.CAL 62751
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20220630_def.xml EX-101.DEF 235102
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20220630_lab.xml EX-101.LAB 701986
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20220630_pre.xml EX-101.PRE 386876
58 EXTRACTED XBRL INSTANCE DOCUMENT brhc10040598_10q_htm.xml XML 1091771
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 221148760
SIC: 2834 Pharmaceutical Preparations